Shanghai Mental Health Center: all 271 studies

Page 3 of 3. Open to participants first (90), then studies with results posted, then the rest; newest registration first within each.

• Study on the Effect of PRKCB1 Modulating Inflammatory Factors and the Role for Developing Major Depressive DisorderStatus unknownNCT03899194Not applicable
• Predict MDE Outcomes After MSTCompletedNCT03841019Not applicable
• Transcranial Magnetic Stimulation for Treatment of Methamphetamine DependenceCompletedNCT03827785Not applicable
• Clinical Evaluation of Acupuncture Treatment for Negative Symptoms of SchizophreniaStatus unknownNCT03802838Phase 4
• The Efficacy of Computerized Cognitive Remediation Therapy for Chronic SchizophreniaCompletedNCT03772951Phase 4
• Transcranial Alternating Current Stimulation (tACS) for Cognitive Impairments in Patients With SchizophreniaStatus unknownNCT03756610Not applicable
• The Effect of Mindfulness-based Relapse Prevention on Impulsive Control Circuit Among Methamphetamine DependentsStatus unknownNCT03748875Not applicable
• Transcranial Magnetic Stimulation for Treatment of Methamphetamine Use DisorderCompletedNCT03736317Not applicable
• The Effect of Repetitive Transcranial Magnetic Stimulation in SchizophreniaWithdrawnNCT03736291Not applicable
• A Study of the Effectiveness of Electronic Interventions on the Standardized Prescription Benzodiazepines and Z-drugsCompletedNCT03724669Not applicable
• Correlation Study Between Mental Behavioral Symptoms in Dementia Patients and Mood Disorders of CaregiversStatus unknownNCT03724344
• The Effect of G-CBT on the Patients With ANStatus unknownNCT03684239Not applicable
• Effects of Hyperprolactinemia Induced by Antipsychotic Drugs on Bone MetabolismStatus unknownNCT03675750
• The China Longitudinal Aging Study of Cognitive ImpairmentStatus unknownNCT03672448
• Effects of Oxytocin on Negative Symptoms and Social Cognition in Schizophrenia and Its Possible MechanismsCompletedNCT03662425Not applicable
• Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination TherapyCompletedNCT03652974Phase 4
• Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Obsessive Compulsive DisorderCompletedNCT03649685Not applicable
• Modulation of Repetitive Transcranial Magnetic Stimulation on Hippocampal Neurogenesis and Functional Network in Patients With SchizophreniaStatus unknownNCT03608462Not applicable
• High-Definition Transcranial Direct Current Stimulation as a Treatment of Negative Symptoms of SchizophreniaTerminatedNCT03602716Not applicable
• The Study of Mindfulness-based Cognitive Therapy and Major Depressive DisorderStatus unknownNCT03558256Not applicable
• Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments(SMART-CAT)CompletedNCT03510325Phase 3
• The Effect of G-DBT on the Patients With BN : A Multicenter Randomized Controlled StudyCompletedNCT03455088Not applicable
• Long-term Follow-up Study of Substance Abuse Screening and Intervention in Multi Primary Care CentersCompletedNCT03452241Not applicable
• A Electronic System to Improve Recovery Outcomes in Patients With Drug Use DisorderCompletedNCT03451344Not applicable
• a Pilot Study of Pramipexole to Treat Extrapyramidal Symptoms Induced by AntipsychoticsCompletedNCT03430596Early Phase 1
• Adjunctive Selective Estrogen Receptor Modulators on Negative and Cognitive Symptoms of Schizophrenia in WomenCompletedNCT03418831Phase 4
• Simplified Cognitive Behavioral Therapy for Generalized Anxiety Disorder and DepressionStatus unknownNCT03329287Not applicable
• The Application of Cognitive Rehabilitation Therapy for Amphetamine-type Stimulants AddictionCompletedNCT03318081Not applicable
• Octohydroaminoacridine Succinate Tablet for Mild-to-Moderate Alzheimer's DiseaseStatus unknownNCT03283059Phase 3
• Validating and Optimizing Model of Antipsychotics SelectionStatus unknownNCT03237052Not applicable
• The Application of Music Therapy in Female Amphetamine Use DisorderCompletedNCT03221283Not applicable
• Multi-Dimensional Diagnosis,Individualized Therapy,and Management Technique for Major Depressive Disorder:Based on Clinical and Pathological CharacteristicsStatus unknownNCT03219008Phase 4
• Comparison of Anyu Peibo With Placebo in Treatment of MDD，ⅡbCompletedNCT03183505Phase 2
• The Study of Mindfulness Based Cognitive Therapy and Obsessive-Compulsive DisorderCompletedNCT03179839Not applicable
• Magnetic Seizure Therapy for Bipolar ManiaCompletedNCT03160664Not applicable
• Magnetic Seizure Therapy vs. Electroconvulsive Therapy for Bipolar ManiaWithdrawnNCT03016104Not applicable
• Sodium Butyrate For Improving Cognitive Function In SchizophreniaWithdrawnNCT03010865Phase 2/3
• Magnetic Seizure Therapy Versus Electroconvulsive Therapy for SchizophreniaCompletedNCT03007628Not applicable
• 50 Hz vs. 25 Hz Magnetic Seizure Therapy for SchizophreniaCompletedNCT03003156Not applicable
• Acceptance and Commitment Therapy in SSRI-Resistant Obsessive Compulsive DisorderWithdrawnNCT02955654Not applicable
• Substance Use Screening Among Drug UserStatus unknownNCT02951858Not applicable
• The Novel Addiction Assessment Study in Synthetic Drugs AddictionCompletedNCT02950376
• Relapse Predicting Model for First Episode DepressionStatus unknownNCT02942251Not applicable
• The Optimal Treatment for Treatment-resistant SchizophreniaStatus unknownNCT02926976Not applicable
• Repetitive Transcranial Magnetic Stimulation for the Treatment of Negative Symptoms in Schizophrenia Patients.Status unknownNCT02842034Not applicable
• Repetitive Transcranial Magnetic Stimulation for the Treatment of the Tardive Dyskinesia.Status unknownNCT02840760Not applicable
• Transcranial Direct Current Stimulation (tDCS) as a Treatment for Cognitive Deficits in SchizophrenicCompletedNCT02748083Not applicable
• Magnetic Seizure Therapy for SchizophreniaTerminatedNCT02746965Not applicable
• The Study of the Pathogenesis and Cognitive Behavioral Group Therapy in Obsessive-Compulsive DisorderCompletedNCT02739061Not applicable
• Novel Intervention for Amphetamine-type Stimulants AddictionCompletedNCT02713815Not applicable
• The Influence of Omega-3 Fatty Acid on the Violence of Schizophrenia Patient and the Possible MechanismStatus unknownNCT02552758Not applicable
• Comparison of Yuxintine With Placebo in Treatment of MDDStatus unknownNCT02395263Phase 2
• Comparison of Anyu Peibo With Placebo in Treatment of MDDCompletedNCT02380066Phase 2
• The Diagnostic Assessment and Intervention Study of Amphetamine Type StimulusCompletedNCT02285556Not applicable
• Comparison of Orcinoside With Placebo in Treatment of MDDCompletedNCT02191384Phase 2
• The Efficacy And Cognitive Impairment Of Modified Electroconvulsive TherapyCompletedNCT02066077Not applicable
• Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD PatientsCompletedNCT02022709Phase 4
• Algorithm Guided Treatment Strategies for Bipolar DepressionStatus unknownNCT01938859Phase 4
• The Study of microRNA 107 (miRNA 107) and Beta-amyloid Precursor Protein-cleaving Enzyme 1 (BACE1) Messenger Ribonucleic Acid (mRNA) Gene Expression in Cerebrospinal Fluid and Peripheral Blood of Alzheimer's DiseaseStatus unknownNCT01819545
• Algorithm Guided Treatment Strategies for Major Depressive DisorderStatus unknownNCT01764867Phase 4
• Reducing Hepatitis C Virus (HCV)/Human Immunodeficient Virus (HIV) Risk Behaviors Among Injection Drug Users in ChinaCompletedNCT01647191Not applicable
• School-based Comprehensive Suicide Intervention in Shanghai, ChinaStatus unknownNCT01598519Not applicable
• Efficacy Evaluation of Traditional Chinese Medicine JITAI Combined Comprehensive Model Among Heroin Addicts After DetoxificationCompletedNCT01580163Not applicable
• Research of Prevention and Intervention of Mental Health ProblemsCompletedNCT01422447Not applicable
• The Efficacy and Safety of AChE Inhibitor Donepezil As Adjunctive Treatment to Mood Stabilizers in Acute ManiaCompletedNCT01191918Phase 4
• Effect Study of Optimized Intervention to Heroin AddictsStatus unknownNCT01144390Not applicable
• A Study to Evaluate the Pharmacokinetics of Duloxetine in Chinese Han Healthy SubjectsCompletedNCT00933452Phase 1
• A Study To Evaluate The Efficacy And Safety Of Intramuscular Levosulpiride In Patients With Agitation Of SchizophreniaCompletedNCT00866645Phase 2/3
• A Clinical Trial to Evaluate the Efficacy and Safety of Generic Escitalopram in DepressionCompletedNCT00866593Phase 2/3
• A Study to Evaluate the Efficacy and Safety of Seroquel in Chinese Han Patients With SchizophreniaCompletedNCT00817648Phase 4
• Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's DiseaseCompletedNCT00800709Phase 4

← Shanghai Mental Health Center overview and focus areas